Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1 Gynecologic 1

Conditions

Hemorrhage 1 Bone Neoplasms 1

Interventions

Doxorubicin 40 Radiotherapy 30 Ifosfamide 28 Vincristine 27 Cyclophosphamide 24 Imatinib Mesylate 20 Etoposide 20 Dactinomycin 14 Radiation 13 Filgrastim 11 Temozolomide 9 Sunitinib 9 Trabectedin 8 Methotrexate 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 6 Granulocyte Colony-Stimulating Factor 6 Chemotherapy, Adjuvant 6 pazopanib 5 nilotinib 5 Zoledronic Acid 5 Neoadjuvant Therapy 5 Irinotecan 5 Cisplatin 5 Carboplatin 5 X-Rays 4 Vinorelbine 4 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fibrin Tissue Adhesive × Sarcoma × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡